25-Hydroxyvitamin D3 1α-hydroxylase splice variants in breast cell lines MCF-7 and MCF-10

Cancer Genomics and Proteomics

Volumn 4, Issue 4, 2007, Pages 295-300

  Fischer, D ^a   Seifert, M ^b   Becker, S ^a   Ludders D ^a   Cordes, T ^a   Reichrath, J ^b   Friedrich, M ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

1 hydroxylase; MCF 10; MCF 7; Splice variants; Vitamin D3

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCIFEDIOL; ENZYME VARIANT; RNA;

AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; HYDROXYLATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; RNA SPLICING; TRANSLATION REGULATION; WESTERN BLOTTING; ALTERNATIVE RNA SPLICING; BREAST TUMOR; EXON; FEMALE; GENETIC VARIABILITY; GENETICS; MOLECULAR CLONING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ALTERNATIVE SPLICING; BREAST NEOPLASMS; CELL LINE, TUMOR; CLONING, MOLECULAR; EXONS; FEMALE; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; VARIATION (GENETICS);

EID: 34249309156     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ferlayj J, Bray F, Sankila R and Parkin D 2002 GLOBOCAN: Cancer incidence, mortality and prevalence worldwide, Version 2.0. IARC Press, Lyon.
2. Cui Y and Rohan TE: Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev 15(8): 1427-1437, 2002.
3. Colston KW and Hansen CM: Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 9: 45-59, 2002.
4. 3-24-hydroxylase in rat osteoblasts. Endocrinology 134: 1794-1799, 1994.
5. Mawer EB, Walls J, Howell A, Davies M, Ratcliffe WA and Bundred NJ: Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab 82: 118-122, 1997.
6. Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC and Hankinson SE: Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14: 1991-1997, 2005.
7. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG and Colston KW: Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 41: 1164-1169, 2005.
8. Colston KW, Lowe LC, Mansi JL and Campbell MJ: Vitamin D status and breast cancer risk. Anticancer Res 26(4A): 2573-2580, 2006.
9. Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W and Reichrath J: Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res 164: 239-246, 2003.
10. Zehnder D, Bland R, Williams MC, Mc Ninch RW, Howie AJ, Stewart PM and Hewison M: Extrarenal expression of 25-hydroxyvitamin D(3)-1α-hydroxylase. J Clin Endocrinol Metab 86: 888-894, 2001.
11. Welsh J, Wietzke JA, Zinser GM, Byrne B, Smith K and Narvaez CJ: Vitamin D-3 receptor as a target for breast cancer prevention J Nutr 133: 2425-2433, 2003.
12. Hewison M, Zehnder D, Bland R and Stewart PM: 1α-Hydroxylase and the action of vitamin D. J Mol Endocrinol 25: 141-148, 2000.
13. Hewison M, Zehnder D, Chakraverty R and Adams JS: Vitamin D and barrier function: a novel role for extra-renal 1α-hydroxylase. Mol Cell Endocrinol 215: 31-38, 2004.
14. Stimpfl M, Tong D, Fasching B, Schuster E, Obermair A, Leodolter S and Zeillinger R: Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer. Clin Cancer Res 8: 2253-2259, 2002.
15. Diesel B, Radermacher J, Bureik M, Bernhardt R, Seifert M, Reichrath J, Fischer U and Meese E: Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol. Clin Cancer Res 11: 5370-5380, 2005.
16. 31alpha-hydroxylase in brain and skin cancer. J Steroid Biochem Mol Biol 89-90: 527-532.1, 2005.
17. Maas RM, Reus K, Diesel B, Steudel WI, Feiden W, Fischer U and Meese E: Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D(3) 1,alpha-hydroxylase (CYP 27B1) in human malignant glioma. Clin Cancer Res 7: 868-875, 2001.
18. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method Methods 4: 402-408, 2001.
19. 3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha- hydroxylated vitamin D analogue. Breast Cancer Res 7: R980-986, 2005.
20. Friedrich M, Diesing D, Cordes T, Fischer D, Becker S, Chen TC, Flanagan JN, Tangpricha V, Gherson I, Holick MF and Reichrath J: Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in normal and malignant breast tissue. Anticancer Res 26: 2615-2620, 2006.
21. Ner-Gaon H, Halachmi R, Savaldi-Goldstein S, Rubin E, Ophir R and Fluhr R: Intron retention is a major phenomenon in alternative splicing in Arabidopsis. Plant J 39: 877-885, 2004.
22. Hiller M, Huse K, Platzer M and Backofen R: Non-EST based prediction of exon skipping and intron retention events using Pfam information. Nucleic Acids Res 33: 5611-5621, 2005.
23. Galante PA, Sakabe NJ, Kirschbaum-Slager N and de Souza SJ: Detection and evaluation of intron retention events in the human transcriptome. RNA 10: 757-765, 2004.
24. Hube F, Guo J, Chooniedass-Kothari S, Cooper C, Hamedani MK, Dibrov AA, Blanchard AA, Wang X, Deng G, Myal Y and Leygue E: Alternative splicing of the first intron of the steroid receptor RNA activator (SRA) participates in the generation of coding and noncoding RNA isoforms in breast cancer cell lines. DNA Cell Biol 25: 418-428.12, 2006.
25. 3 on primary mouse epidermal keratinocyte proliferation. J Cell Physiol 163: 248-256, 1995.
26. Diesing D, Cordes T, Fischer D, Diedrich K and Friedrich M: Vitamin D-metabolism in the human breast cancer cell line MCF-7. Anticancer Res 26: 2755-2759, 2006.
27. Townsend K, Banwell CM, Guy M, Colston KW, Mansi JL, Stewart PM, Campbell MJ and Hewison M: Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res 11: 3579-3586, 2005.
28. Townsend K, Evans KN, Campbell MJ, Colston KW, Adams JS and Hewison M: Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 97: 103-109, 2005.
29. Grant WB: The likely role of vitamin D from solar ultraviolet-B irradiance in increasing cancer survival. Anticancer Res 26: 2605-2614, 2006.